Health Care & Life Sciences » Biotechnology | Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc. | Mutual Funds

Mutual Funds that own Pacific Biosciences of California Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
American Funds Small Cap World Fund
9,377,456
7.11%
-920,621
0.12%
06/30/2018
ARK Innovation ETF
4,146,571
3.14%
0
1.46%
09/05/2018
Vanguard Total Stock Market Index Fund
3,334,838
2.52%
0
0%
07/31/2018
ARK Genomic Revolution Multi Sector ETF
2,951,374
2.24%
16,479
4.78%
09/05/2018
Meridian Small Cap Growth Fund
2,586,789
1.96%
0
0.78%
03/31/2018
iShares Russell 2000 ETF
2,549,767
1.93%
-1,362
0.03%
09/06/2018
iShares Nasdaq Biotechnology ETF
1,530,729
1.15%
-20,013
0.08%
09/06/2018
Vanguard Extended Market Index Fund
1,513,105
1.14%
0
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
1,186,019
0.9%
0
0.05%
09/06/2018
Fidelity Spartan Extended Market Index Fund
502,855
0.38%
0
0.01%
07/31/2018

About Pacific Biosciences of California

View Profile
Address
1305 O'Brien Drive
Menlo Park California 94025
United States
Employees -
Website http://www.pacb.com
Updated 07/08/2019
Pacific Biosciences of California, Inc. engages in the research, development, and manufacture of sequencing systems for genetic analysis. It operates through the following geographical segments: North America, Europe, and Asia Pacific (including the Middle East). The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.